2 results
Approved WMOCompleted
To evaluate the safety and clinical performance of the LCP system in patients who are indicated for VVI(R) pacemaker.
Approved WMOCompleted
MAIN OBJECTIVEDose escalation phase :- To determine the MTD and/or RDE of alpelisib (BYL719) in combination with everolimus, and the MTD and/or RDE of alpelisib in combination with everolimus and exemestaneDose expansion part:- To describe safety…